Skip to main content

Table 1 Methods used to assess CSF biomarkers

From: Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers

CSF analyte

Biology indexed

42 (β-amyloid 1-42)

Elecsys β-amyloid 1-42 CSF performed at Roche Diagnostics, Indianapolis, IN

Parenchymal amyloid accumulation

p-tau181 (tau phosphorylated at threonine 181)

Elecsys Phospho-Tau (181P) CSF performed at Roche Diagnostics, Indianapolis, IN

Tau tangle pathology

NfLa (neurofilament light chain)

Uman, performed at Immunologix, Tampa, FL

Neuroaxonal degeneration

Nga (neurogranin)

Euroimmune, performed at Immunologix, Tampa, FL)

Postsynaptic injury

YKL-40a (chitinase-3-like protein 1)

ELLA (Protein Simple), performed at Immunologix, Tampa, FL)

Microglial and astrocyte activation [39]

  1. aAll CSF samples for NfL, Ng, and YKL-40 were tested using a single batch of reagents